银屑病患者的睡眠障碍:一项病例对照研究
该横断面病例对照研究纳入179例连续性招募的斑块状银屑病患者和105例对照,比较睡眠障碍患病率并分析其与健康相关生活质量及疾病相关预测因素的关系。结果显示银屑病患者临床失眠和睡眠质量差的比例均高于对照,瘙痒与所有睡眠结局显著相关,是睡眠受损的主要预测因素。
要点
- 银屑病患者临床失眠(ISI>15)比例为25%,对照组为10.5%。
- 银屑病患者睡眠质量差(PSQI>5)比例为53.6%,对照组为21.9%。
- 瘙痒与所有睡眠相关结局显著相关,是睡眠受损的主要预测因素。
核心结论
- 银屑病患者中睡眠质量差的比例高于一般人群对照组,瘙痒是睡眠受损的主要预测因素。
- 改善银屑病控制以减少瘙痒可能改善银屑病患者的睡眠障碍。
研究设计与样本
- 采用横断面病例对照设计,纳入179例连续性招募的斑块状银屑病患者和105例对照。
- 评估指标包括银屑病面积和严重程度指数、皮肤病生活质量指数、失眠严重程度指数、匹兹堡睡眠质量指数、感知压力量表、瘙痒严重程度量表和贝克抑郁量表。
- 分析包括组间比较和回归分析以识别睡眠障碍的预测因素。
主要发现
- 银屑病患者中25%报告临床失眠(ISI>15),对照组为10.5%。
- 银屑病患者中53.6%为睡眠质量差(PSQI>5),对照组为21.9%。
- 瘙痒与所有睡眠相关结局呈统计学显著相关。
关键数值与推荐
- 临床失眠定义为失眠严重程度指数(ISI)>15,银屑病患者为25%,对照组为10.5%。
- 睡眠质量差定义为匹兹堡睡眠质量指数(PSQI)>5,银屑病患者为53.6%,对照组为21.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep is essential for daytime functioning and health. Given the physical symptoms of psoriasis, a higher prevalence of sleep disorders can be expected. So far, the studies examining sleep disturbance in psoriasis have been of less-than-optimal methodological quality and with mixed results. OBJECTIVES: To examine the prevalence of sleep disturbance in patients with plaque psoriasis compared with a control group, to evaluate associations with health-related quality of life (HRQoL) and examine possible disease-related predictors of disturbed sleep. METHODS: We used a cross-sectional, case-controlled design. Participants included 179 consecutively recruited patients with plaque psoriasis and 105 controls. Measures included psoriasis severity (Psoriasis Area and Severity Index); HRQoL (Dermatology Life Quality Index); insomnia severity [Insomnia Severity Index (ISI)]; sleep quality [Pittsburgh Sleep Quality Index (PSQI)]; stress (Perceived Stress Scale); itch (Itch Severity Scale); and depressive symptoms (Beck Depression Inventory). Analyses included group comparisons and regression analyses to identify predictors of sleep disturbance. RESULTS: A total of 25% of patients with psoriasis reported clinical insomnia (ISI > 15), compared with 10·5% of controls. In all, 53·6% of patients with psoriasis were poor sleepers (PSQI > 5), compared with 21·9% of controls. Itch was statistically significantly associated with all sleep-related outcomes. CONCLUSIONS: A higher proportion of patients with psoriasis experience poor sleep than controls from the general population. Itch was the main predictor of impaired sleep. Improved control of psoriasis with decreased itch may improve sleep disturbance in psoriasis.
引用
- Jensen P, Zachariae C, Skov L, et al. Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol. 2018. PMID: 29704428. doi:10.1111/bjd.16702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。